- Home
- BOLD vs NYC Comparison
BOLD vs NYC Comparison
Compare BOLD & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | BOLD | NYC |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.7M | 23.5M |
| IPO Year | 2024 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BOLD | NYC |
|---|---|---|
| Price | $1.12 | $8.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 63.7K | 1.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.47 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.40 |
| Revenue Next Year | N/A | $1.62 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.96 | $7.03 |
| 52 Week High | $1.78 | $16.30 |
Technical Indicators
Market Signals| Indicator | BOLD | NYC |
|---|---|---|
| Relative Strength Index (RSI) | 39.80 | 42.55 |
| Support Level | $1.10 | $7.12 |
| Resistance Level | $1.20 | $8.28 |
| Average True Range (ATR) | 0.03 | 0.31 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 0.00 | 7.81 |
Price Performance
Historical ComparisonAbout BOLD Boundless Bio Inc.
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.